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Abstract
Background: In July 2010 a new multiple hub-and-spoke model for acute stroke care was implemented across the whole of
London, UK, with continuous specialist care during the first 72 hours provided at 8 hyper-acute stroke units (HASUs)
compared to the previous model of 30 local hospitals receiving acute stroke patients. We investigated differences in clinical
outcomes and costs between the new and old models.
Methods: We compared outcomes and costs ‘before’ (July 2007–July 2008) vs. ‘after’ (July 2010–June 2011) the introduction
of the new model, adjusted for patient characteristics and national time trends in mortality and length of stay. We
constructed 90-day and 10-year decision analytic models using data from population based stroke registers, audits and
published sources. Mortality and length of stay were modelled using survival analysis.
Findings: In a pooled sample of 307 patients ‘before’ and 3156 patients ‘after’, survival improved in the ‘after’ period (age
adjusted hazard ratio 0.54; 95% CI 0.41–0.72). The predicted survival rates at 90 days in the deterministic model adjusted for
national trends were 87.2% ‘before’ % (95% CI 86.7%–87.7%) and 88.7% ‘after’ (95% CI 88.6%–88.8%); a relative reduction in
deaths of 12% (95% CI 8%–16%). Based on a cohort of 6,438 stroke patients, the model produces a total cost saving of £5.2
million per year at 90 days (95% CI £4.9-£5.5 million; £811 per patient).
Conclusion: A centralized model for acute stroke care across an entire metropolitan city appears to have reduced mortality
for a reduced cost per patient, predominately as a result of reduced hospital length of stay.
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Introduction
Stroke is a leading cause of mortality and disability worldwide.
[1] Organized inpatient stroke care has been shown to decrease
morbidity and mortality. In a review of 31 randomized controlled
trials comparing stroke unit (SU) care with an alternative service,
SUs were associated with lower risk of death at one year (odds
ratio (OR) 0.86; P=0.02), of death or institutionalized care (OR
0.82; P=0.0006) and death or dependency (OR 0.82; P=0.001)
[2]. A large observational study in New York State showed
improved mortality at one day, 30 days (2.5% absolute reduction
in adjusted 30 day all-cause mortality) and one year in patients
treated in designated stroke centers compared to patients admitted
to non-designated hospitals after acute ischemic stroke [3]. While
there is evidence that outcomes are better in more organized
services [2], little is known about the benefits of intensive specialist
stroke care in the first 72 hours after stroke. It is also not known
PLOS ONE | www.plosone.org 1 August 2013 | Volume 8 | Issue 8 | e70420whether centralizing acute stroke care to a small number of high
volume specialist centers can provide better outcomes across a
large metropolitan city and whether such a model is cost effective.
In 2006 a report by Professor Lord Ara Darzi recommended
greater specialized acute care delivered in dedicated, high-volume
stroke units [4]. The aim was to provide a uniform high-quality
standard of care, including rapid assessment and treatment for all
stroke patients in London irrespective of location, 24 hours a day,
seven days a week. At this time, the dominant model of care for
acute stroke patients in London as well as the rest of England
centered on local hospital care. Thirty of London’s hospital had
designated stroke units (SUs), but a national audit of all stroke
units in England in 2008 identified that improvements in stroke
care in London had been slower than the rest of England [5].
Following Lord Darzi’s recommendation, a London-specific
stroke strategy was published in 2008 [6]. This made a number of
recommendations regarding the prevention of stroke, provision of
acute stroke services, and rehabilitation of stroke patients. One of
the most significant recommendations was the rapid implemen-
tation of a new model of acute care with a small number of highly
specialist units providing hyper-acute stroke care in the first 72
hours for all suspected stroke patients and, in addition, a larger
number of acute stroke units with enhanced specialist care and
multi-therapy rehabilitation for those patients requiring ongoing
in-patient care beyond 72 hours.
The stroke care model was co-created through a series of events
with key stakeholders, clinical experts, patients and carers as well
as representatives from carer groups.
For a unit to be accredited as a hyper-acute stroke unit (HASU)
or SU it had to meet pre-defined service specifications, including
high minimum staffing levels, assessed by an independent expert
panel. The model was supported by extra investment, via an
enhanced tariff for each patient [7].
The new model for stroke care was introduced in July 2010.
Eight HASUs were created to provide faster response times to a
suspected stroke, and continual access to specialist care throughout
the first 72 hours. This was complemented by SUs for on-going
inpatient care if necessary after 72 hours (see Figure 1 for a stylized
depiction of the ‘before’ and ‘after’ stroke models).
We sought to determine the clinical outcomes (adjusted all-
cause mortality) and cost-effectiveness of the new London model at
90 days and 10 years after admission to hospital using two cost-
effectiveness models. Randomised trials in this area are challeng-
ing if not impossible because of the nature of the intervention,
which is a city-wide reconfiguration of services. Hence, we used a
before-and-after study design, adjusting for national trends and
comparing costs and outcomes of stroke patients in London
between July 2007–June 2008 and July 2010–June 2011 using a
population based stroke register and audit data. The ‘before’
period was the most recent period before the new model was
introduced in any part of London.
Methods
Ethics
Patients or their relatives provide informed consent for
collection and storage of their data for the South London Stroke
Register (SLSR). All other data sources contained de-identified
patient data collected for the purpose of service evaluation or audit
and hence ethics approval was not required.
Figure 1. Stylized depiction of new and previous stroke model.
A Previous model (‘before’). B New model (‘after’). Abbreviations: A&E –
Accident and Emergency Department; ASU – Acute Stroke Unit; HASU –
Hyper Acute Stroke Unit; ESD – Early Supported Discharge.
doi:10.1371/journal.pone.0070420.g001
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A stylized depiction of the stroke models before and after
reconfiguration are in Figure 1 and Supplementary Appendix
Figure S1 in File S1.
Study Population
Our study population was patients who had an ischemic or
hemorrhagic stroke in London between July 2007–June 2008 and
July 2010–June 2011. The main data sources were: the SLSR; an
audit from two North London hospitals; the London Minimum
Dataset (LMDS); the Stroke Improvement National Audit
Programme (SINAP); the national Sentinel Stroke Audit; and,
the London Ambulance Service.
The SLSR is a population-based stroke prospective registry
recording all first-ever strokes in patients of all ages living in an
area of South London. [8,9] Data on long-term outcomes and
utilization of hospital and community care services up to July 2011
were extracted for patients with a stroke-related hospital admission
date from July 2007–June 2008 for the ‘before’ period and July
2010–January 2011 for ‘after’. Stroke diagnosis was ascertained by
a physician and patients were followed up via structured
questionnaire at 48 hours and three months, and yearly thereafter.
[9].
Outcomes and resource data for the inpatient component of the
stroke pathway were collected from a retrospective audit of all
patients admitted to two large North London hospitals with a
diagnosis of stroke between April–June 2008 and April–June 2011.
Data for the ‘after’ period only were obtained from SINAP and
the LMDS. These retrospective datasets included all patient
admissions for stroke from January–June 2011 in London, and
combined they covered the stroke pathway from hospital
admission to discharge, with data on mortality and length of
hospital stay. Because they were available for the ‘after’ period
only, we ran models with and without these data.
Sentinel is the national stroke audit conducted from April to
June every two years, covering the stroke pathway from stroke
onset to discharge from acute care, based on data for the first 60
consecutive stroke cases in all acute hospitals in England. Data
from the Sentinel audits in 2008 and 2010 were used to adjust for
changes in mortality and LOS that occurred elsewhere in the
country during this period. [5,10].
Information on time from emergency call to arrival at hospital
was provided by the London Ambulance Service (LAS) for 23,365
stroke patients ‘before’ (January 2005–March 2008), identified by
their illness code, and 7,375 stroke patients ‘after’ (July 2010–May
2011), identified using a pre-hospital stroke screen.
See Table S1 in File S1 for more details.
Outcome Measures
Survival time was measured from the first date of admission to
hospital until date of death. The censoring point for patients with
no death record was the date of hospital discharge (North London
dataset) or the last update date (SLSR and SINAP/LMDS).
Date of admission, date of discharge and discharge location
were available in all three datasets, and used to calculate LOS and
discharge location by ward type.
‘Health States’ in the 90-day model were based on ward type
and discharge location. Each state was assigned a mean cost per
patient per day and utility score. We accounted for differences in
costs and admission rates by type of stroke and thrombolysis rates.
Utilities to calculate quality-adjusted life-years (QALYs) were
derived from the Barthel index, available in the SLSR and North
London data, using a new UK algorithm [11].
We calculated mean ambulance travel times and resources
required from time of emergency call to arrival at hospital.
For further details on utilities and unit costs see Table S2–S3 in
File S1.
Statistical Analysis
To investigate differences in ‘before’ and ‘after’ survival, we ran
semi-parametric (Cox proportional hazards) and parametric
(Weibull) survival models. We also controlled for age in these
models. We only controlled for age because no other variables had
a significant impact on the results, and we wanted a parsimonious
model to more easily incorporate the results into the economic
analysis. The time dependent hazard of death from hospital
admission was calculated using separate survival models for each
period to allow different shape parameters for the two mortality
estimates.
Time-dependent movements between wards and discharge
locations for the 90-day model were calculated similarly using
parametric survival models, controlling for destination ward and
discharge location.
Measuring Cost-effectiveness
Cost-effectiveness was measured in terms of the incremental
cost per death averted at 90 days after hospital admission, and the
incremental cost per QALY gained at 90 days and 10 years after
hospital admission. We constructed two time-dependent Markov
models [12] (see Methods S1–S2 in File S1), each with a
hypothetical population of 6,438 strokes in London, based on
2009/10 Hospital Episode Statistics. [13] The first model covers time
from admission to 90 days (one day cycles) and the second from 90
days to 10 years (90 day cycles). Transition probabilities were time-
dependent and varied by days from admission to hospital.
Transition probabilities for the 90 day to 10 year model are
reported in Table S4 in File S1 and corresponding Barthel Index
categories are in Table S5 in File S1. See Figure S2 in File S1 for a
stylized depiction of the 90 days to 10 years model.
Costs were measured using an English National Health Service
and Personal Social Services perspective, [14] in 2010/11 UK£.
We measured costs of transport, acute hospitalisation, imaging and
surgical interventions, staff contacts, medications during acute
hospitalisation and post-discharge care (see Table S1 in File S1).
To account for the before-and-after nature of our analysis we
adjusted for national trends in mortality and LOS, the main
drivers of costs and outcomes, using Sentinel Stroke Audit data.
We reduced the number of deaths at 30 days in the ‘before’ period
to reflect that across England, excluding London, there was a drop
in the number of stroke patients that died at 30 days by 2.4
percentage points between 2008 and 2010 (20.7% vs. 18.3%).
[10,5] We reduced the LOS on the SU in the before period to
reflect that across England, excluding London, there was a drop in
mean LOS on a SU of 5.0 days between 2008 and 2010 (23.1 days
vs. 18.1 days). [10,5].
We undertook a probabilistic sensitivity analysis based on
10,000 simulations of the models. We used this to compute
confidence intervals for point estimates of cost-effectiveness and to
draw cost-effectiveness acceptability curves. In the 10 year model
costs and QALYs were discounted at an annual rate of 3.5%. [14].
See Methods S3 and Table S6 in File S1 for sensitivity analysis
details.
The reporting of this study conforms with the EVEREST
statement.
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The sample for the 90-day model comprised 307 patients
‘before’, 3,156 patients ‘after’ (Table 1); we also present results for
‘after’ using 319 North London and SLSR patients only (the
datasets available in the ‘before’ period). The three samples were
similar in terms of age, gender and stroke type (Table 1).
The adjusted hazard ratio of dying from stroke ‘after’ versus
‘before’ was 0.54 (95% CI 0.41–0.72; Figure 2) for the central
estimate; 0.56 (95% CI 0.33–0.94) using North London and SLSR
data only.
The (unadjusted) Kaplan-Meier survival rate at 90 days was
81.5% ‘before’ (95% CI 76.0%–85.9%) and 88.7% ‘after’ (95% CI
87.4%–89.9%), with a 39% reduction in deaths at 90 days (95%
CI 11%–58%). The predicted survival rates at 90 days in the
deterministic unadjusted model were 85.0% ‘before’ (95% CI
84.5%–85.5%) and 88.7% ‘after’ (95% CI 88.6%–88.8%); a
reduction in deaths of 25% (95% CI 21%–28%). Survival at 90
days in the ‘before’ model increased to 87.2% (95% CI 86.7%–
87.7%) when the model was adjusted for the decrease in deaths at
30 days seen over the same period in the rest of England, giving a
reduction in adjusted deaths of 12% (95% CI 8%–16%).
Around 50% of patients ‘before’ were admitted initially to an
SU and around 10% were in the SU or stroke rehabilitation at 90
days (Figure 3). ‘After’, three-quarters of patients were admitted
initially to a HASU and less than 1% were in the HASU or the SU
at 90 days. Around 5% of patients were discharged to a nursing
home and 60% home at 90 days ‘before’ compared with 1% and
70%, respectively ‘after’ (See Figures S3–S6 in File S1).
Mean ambulance response times and scene-to-hospital times
increased in the ‘after’ period. From January 2005–March 2008
the mean time from emergency call to arrival at hospital was 50
minutes and scene-to-hospital time was 14 minutes. From July
2010–May 2011 they were 62 and 17 minutes, respectively.
Table 1. Comparison of ‘before’ and ‘after’ sample and resource use.
Before Period After Period (1) After Period (2)
North London and SLSR
North London, SLSR and
SINAP/LMDS North London and SLSR only
Databases (n)
SLSR 205 100 100
North London Database 102 219 219
SINAP/LMDS 2,837
Total 307 3,156 319
Age (Mean (SD) 71(15.2) 72.8(14.86) 71.6(15.2)
Gender (% male (n)) 51%(156) 51%(1612) 53%(315)
Stroke type (% (n))
Ischemic 85%(254) 88%(2,768) 86%(212)
Hemorrhagic 15%(44) 12%(371) 14%(35)
Thrombolysis (intravenous) (% (n)) 5% (61) [10] 13% (412) 12%(31)
LOS: first ward admitted (median days (n))
HASU 3 (2352) 2(207)
ASU 4 (141)
SU 3 (425) 12(7)
Stroke rehabilitation 4 (45)
Medical ward 2 (71) 3 (303) 2(42)
Surgical ward 5 (9) 3 (3) 3(3)
ICU 4?5 (16) 4 (47) 3?5(6)
Imaging and surgical interventions (% (n))
Head CT Scan (non-contrast)* 95% (279) 94% (2935) 92%(195)
Head MRI Scan (non-contrast)* 51% (139) 68% (121) 68% (121)
CT Angiography* 40% (104) 63% (133) 63% (133)
Echocardiogram (transthoracic)* 28% (80) 49% (111) 49% (111)
Carotid Stenting 11% (11) 14% (20) 14% (20)
Neurosurgery 6% (6) 1% (3) 1% (3)
Outcomes – Admission
Barthel Index (Mean (SD)) 9?3( 7 ?6) 10?7( 7 ?8) 10?7( 7 ?8)
Health Utility [11] (Mean (SD)) 0?23 (0?31) 0?30 (0?32) 0?30 (0?32)
*Patients may receive more than 1.
Abbreviations: SLSR – South London Stroke Register; SINAP – Stroke Improvement National Audit Programme; LMDS – London Minimum Dataset; SD – Standard
Deviation;L O S–Length of Stay; HASU – Hyper Acute Stroke Unit; ASU – Acute Stroke Unit; SU – Stroke Unit; ICU – Intensive Care Unit; CT – Computerised
Tomography; MRI – Magnetic Resonance Imaging.
doi:10.1371/journal.pone.0070420.t001
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of all stroke patients increased from 5% in the ‘before’ period to
12% in the ‘after’ period.
At 90 days the new model is less costly and produces better
health outcomes. The 90-day cost per patient to treat a stroke
‘before’ was £14,117 (95% CI £14,092–£14,143; US$22,767
[15]) compared to £13,306 ‘after’ (95% CI £13,286–£13,327;
US$21,460). This translates to a 90-day cost saving of £5.2 million
(95% CI £4.9–£5.5 million; US$8.4 million) across 6,438 patients
in the model (£811 per patient; US$1307).
There were 125 fewer deaths (95% CI 118–132) and 93.59
more QALYs (95% CI 91.82–95.36; 0.015 per patient) during the
first 90 days following admission: the new model saved lives and
produced more QALYs. Basing the analysis only on the North
London and SLSR data, the new model costs £295 (95% CI
£242–£347; US$476) more per patient, with an incremental cost
per death averted of £16,779 (US$27,066) and cost per QALY
gained at 90 days of £56,940 (Table 2).
When the model is carried out to ten years, the new model is
dominant in every scenario tested. The discounted 10-year cost
per patient in the ‘before’ model is £39,614 (95% CI £39,549–
£39,678; US$63,895) compared to £35,745 (95% CI £35,697–
£35,793; US$57,654) ‘after’. Across 6,438 patients costs are
£24.9 million (95% CI £24.1 million–£25.6 million; US$40.2
million) lower ‘after’ compared with ‘before’ and there are 4,193
(95% CI 4166–4221) QALYs gained (0.65 per patient) (Table 3).
Sensitivity analyses show that the findings are consistent after
testing key assumptions (Table 2–3). See Figure 4 for cost-
effectiveness acceptability curves and Figures S7–S8 in File S1 for
results of the Monte Carlo.
Discussion
This study has demonstrated that reconfiguration of acute
stroke care across a metropolitan population of 8 million people
can achieve improved clinical outcomes while also being cost-
effective. Using a 90-day time horizon, the new model costs £811
(US$1307) less per patient, with fewer deaths and improved
quality-adjusted survival. Over 10 years, the effects are maintained
and the new model costs £3868 (US$6233) less per patient.
Prior to the introduction of the new London acute stroke model,
there was marked variation in access to specialised stroke care with
just over half of patients being admitted to designated stroke units
and only 5% of acute stroke patients receiving thrombolysis
treatment. Following the reconfiguration, over 75% of patients
received immediate expert assessment and treatment and throm-
bolysis rates increased to 12%.
Significant financial investments were made to bring about
these changes. It has been estimated that a capital investment of
around £9 million (US$14 million) was made to meet the
requirements for the new HASUs and SUs. [16] If we assume
that the consultation and accreditation process costed a further
£1 million (US$1.6 million), the total implementation cost would
be around £10 million (US$16 million); this investment would be
recouped within around two years according to our figures.
This comparative effectiveness research study has provided
clinical outcome and cost effectiveness data from a very large and
complex clinical service re-organization. The scale of the project
and the requirement for rapid and systematic implementation has
provided several challenges for this evaluation. We have had to use
a variety of data sources and methods to provide results that can
be used by patients, clinicians and policymakers.
Our study has several limitations. One is that before-and-after
study designs are less robust than randomized control trials (RCT)
as the design means less control over confounding variables and
sources of bias. It was not possible to use an RCT design given the
nature of the intervention being evaluated, i.e., city-wide service
reorganization. We tried to account for potential confounders and
biases using several independent, population based data sets to
model the stroke care pathway in London before and after the
introduction of the new model, by being conservative in our
methods and by testing our assumptions in sensitivity analyses. We
adjusted our analyses to reflect national trends in mortality and
LOS, the main drivers of costs and outcomes. Improvements in
mortality and LOS that occurred in London between 2007/08
and 2010/11 were greater than that seen by the rest of the country
over the same period [5,10].
Figure 2. Kaplan-Meier estimates of time from admission to hospital to death comparing ‘before’ and ‘after’. - - - - - Before. ———
After.
doi:10.1371/journal.pone.0070420.g002
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whole of England over the last three years [10]. However the
reduction has been disproportionately greater in London following
the introduction of the new centralized model. This study also
demonstrated a significant increase in thrombolysis rates from 5%
to 12% following the reconfiguration. Although the aim to
improve thrombolysis rates was an important driver in the
development of the new model, it does not fully explain the
QALY gains associated with the reconfiguration, given that
thrombolysis was still only received by a minority of patients.
An RCT from Australia has demonstrated that the implemen-
tation of early, multi-disciplinary supported, evidenced based
protocols targeting important areas such as swallowing substan-
tially improve stroke outcomes up to 90 days after admission for
Figure 3. Patients on stroke units and on the medical ward from stroke onset to 90 days after stroke. A Before period. ——— Acute
Stroke Unit. — —N— Stroke Rehabilitation Unit. -----Medical ward. B After period. ——— Hyper Acute Stroke Unit. — —N— Stroke Unit. -----
Medical ward.
doi:10.1371/journal.pone.0070420.g003
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Diff. in total
costs
Diff. in total
deaths
Inc. cost/death
averted
Diff. in total
QALYs
Inc. cost/QALY
gained
Central estimate (probabilistic) 25,221,877 2125 Dominant 94 Dominant
North London and SLSR data only
(probabilistic)
1,898,440 2113 16,779 33 56,940
Unadjusted for national trends in mortality
and length of stay in stroke
units (probabilistic)
26,765,485 2254 Dominant 118 Dominant
Adjusted for national trends in mortality
but not length of stay in stroke units
(deterministic)
27,144,790 287 Dominant 97 Dominant
Adjusted for national trends in length of
stay in stroke units but not
mortality (deterministic)
21,779,815 2235 Dominant 99 Dominant
Adjustment for stroke mimics (deterministic) 22,371,637 281 Dominant 84 Dominant
Reduced length of stay in HASU
(deterministic)
27,776,818 299 Dominant 89 Dominant
Increase unit cost per day in HASU by 25%
(deterministic)
226,268 298 2,302 86 2,631
Unadjusted length of stay in ICU
(deterministic)
212,508,546 297 Dominant 90 Dominant
Adjusted neurosurgery rates (deterministic) 23,544,210 298 Dominant 86 Dominant
NHS costs only (deterministic) 21,507,197 298 Dominant 86 Dominant
Patients in hospital at three months
discharged to home (deterministic)
23,544,210 298 Dominant 86 Dominant
Total cost, deaths and QALYs calculated over 6438 patients. All costs in 2010/11 UK£ (key figures in US$ in text). In the difference (‘‘Diff.’’) columns negative (positive)
costs, deaths and QALYs mean that costs, deaths and QALYs are lower (higher) in the After period compared with the Before period. ‘‘Dominant’’ means that costs are
lower and either deaths are lower or QALYs are higher in the After period compared with the Before period.
doi:10.1371/journal.pone.0070420.t002
Table 3. Results of cost-effectiveness analysis and sensitivity analysis time horizon 10 years: After minus before.
Diff. in total costs Diff. in total QALYs Inc. cost/QALY gained
Central estimate (probabilistic) 224,905,053 4,193 Dominant
North London and SLSR data only (probabilistic) 22,594,900 2,737 Dominant
Unadjusted for national trends in mortality and length of stay in
stroke units (probabilistic)
223,729,977 4,220 Dominant
Adjusted for national trends in mortality but not length of stay in
stroke units (deterministic)
228,547,614 4,116 Dominant
Adjusted for national trends in length of stay in stroke units but
not mortality (deterministic)
215,831,855 4,385 Dominant
Adjustment for stroke mimics (deterministic) 221,831,909 3,978 Dominant
Reduced length of stay in HASU (deterministic) 227,904,017 4,045 Dominant
Increase unit cost per day in HASU by 25% (deterministic) 218,109,865 4,035 Dominant
Unadjusted length of stay in ICU (deterministic) 233,571,242 4,039 Dominant
Adjusted neurosurgery rates (deterministic) 222,699,835 4,035 Dominant
NHS costs only (deterministic) 191,094 4,035 47
Patients in hospital at three months discharged to home
(deterministic)
214,410,215 4,346 Dominant
Total cost, deaths and QALYs calculated over 6438 patients. All costs in 2010/11 UK£ (key figures in US$ in text). In the 10 year model costs and benefits are discounted
at an annual rate of 3.5%. In the difference (‘‘Diff.’’) columns negative (positive) costs, deaths and QALYs mean that costs, deaths and QALYs are lower (higher) in the
After period compared with the Before period. ‘‘Dominant’’ means that costs are lower and either deaths are lower or QALYs are higher in the After period compared
with the Before period.
doi:10.1371/journal.pone.0070420.t003
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benefits from bundles of care delivered by highly specialised
nursing, therapy and medical teams who are assessing and treating
patients from the time of hospital admission. It is highly probable
that the consolidation of expertise and treating higher volumes of
patients leads to improved diagnosis and overall improved
processes of care. This is more likely to reduce peri-stroke
complications and may therefore explain in part the reduced
mortality observed in our study.
Our results are also consistent with other studies showing that
treating patients in dedicated stroke units is cost-effective, [18,19]
and our calculations of the short- and long-term costs of treating
stroke are similar to previous UK studies. [20].
The only measure available to calculate utility scores for
QALYs from was the BI. Although the BI is a valid measure of
daily living in stroke patients, it is less sensitive to severe and minor
stroke events, suffering from ceiling and floor effects. [21] This
may have resulted in an underestimation of the total QALYs, with
more patients at the higher extremes than at the lower. This would
either have equal impact on the ‘before’ and ‘after’ period if there
was no difference between the two time periods in severity of
stroke, or underestimated the total QALY gain if there was an
improvement in functional impairment in the ‘after’ period, as was
seen.
Our study shows that a system directing patients to high quality
stroke units in the first 72 hours following stroke saves lives and
saves money. This was delivered using a centralized model, which
worked well in London because of the high density population and
hospital distribution that permitted ambulance travel times to
remain within viable limits. While our study could be used to
support the implementation of consolidated hyper-acute stroke
care in other large populations, further research is required to
examine whether the London model is viable in other geograph-
ical and clinical settings.
Supporting Information
File S1 Table S1, Main data sources used to model health
outcomes and volume of resource use. Methods S1, Further details
of short-run model. Methods S2, Further details of long-run
model. Methods S3, Deterministic and probabilistic sensitivity
analysis. Figure S1, Movement of patients in the short-run cost-
effectiveness model from stroke onset to 3 months after stroke
onset. Table S2, EQ-5D utility scores and QALYs. Table S3, Unit
Costs. Figure S2, Movement of patients in the short-run cost-
effectiveness model from 3 months after stroke onset until up to 10
years after stroke onset. Table S4, Transition probabilities in long-
run model. Table S5, Barthel Index categories at three months
after acute stroke among those at home. Table S6, Parameters and
distributions used in the probabilistic sensitivity analysis. Figure
Figure 4. Cost-effectiveness acceptability curves. - - - - - 10 years. ——— 90 days. The curves in the figure graph the probability that the new
London Stroke Service is cost-effective against the cost-effectiveness threshold measured in terms of the incremental cost per QALY gained. This
accounts simultaneously for uncertainty in the cost-effectiveness estimates and in the value of the cost-effectiveness threshold (the level of cost-
effectiveness that the new London Stroke Service needs to be more cost-effective than, i.e., have a lower incremental cost per QALY gained than to
be considered good value for money). In England the cost-effectiveness threshold used by NICE is in the range £20,000–£30,000 per QALY gained
(US$31,000–£46,500 using an exchange rate of UK£1=US$1.55). Curves are shown for each time horizon.
doi:10.1371/journal.pone.0070420.g004
Impact of Centralized Stroke Care in London
PLOS ONE | www.plosone.org 8 August 2013 | Volume 8 | Issue 8 | e70420S3, Distribution of patients between states from stroke onset to 90
days after stroke: Before period. Figure S4, Distribution of patients
between states from stroke onset to 90 days after stroke: After
period. Figure S5, Distribution of patients between states from 90
days to ten years after stroke: Before period. Figure S6,
Distribution of patients between states from 90 days to ten years
after stroke: After period. Figure S7, Monte Carlo simulations of
incremental cost per QALY gained of new London stroke service
using 90-day time horizon. Figure S8, Monte Carlo simulations of
incremental cost per QALY gained of new London stroke service
using ten year time horizon.
(PDF)
Acknowledgments
We would like to thank Denise Chaffer and Sue Dutch from NHS London
for their careful and considerate advice and support during this work.
During the study we have benefited from the advice and suggestions
provided by our Steering Group, which included the following: Mara
Airoldi; Bal Athwal; Roger Boyle; Janice Fawell; David Fish; Tom
Greenwood; Lucy Grothier; Enas Lawrence; Anthony Pereira; Rob
Simister; Mirek Skrypak. The views expressed in this report are not
necessarily those of individual members of the Steering Group.
We are grateful to the organizations who supplied us with data for the
project: London Ambulance Service; South London Stroke Register; Royal
College of Physicians; NW and NC London Cardiac and Stroke Networks;
and, Camden PCT Stroke REACH Early Discharge Scheme.
We would also like to thank the following individuals for their assistance
and advice: Gwyn Bevan; Simone Browning; James Campbell; Adrian
Capp; Siobhan Crichton; Alex Hoffman; Sue Jowett; Billingsley
Kaambwa; Caroline Kilby; Tom Lee; Holly Lynn; Stuart Mallett; Omer
Saka; Gemma Snell; Kerry Thompson; Binta Umar; Gurkamal Virdi;
Charles Wolfe and John Young.
Author Contributions
Conceived and designed the experiments: RH SM CD AR AT. Analyzed
the data: RH SM. Contributed reagents/materials/analysis tools: CD AR
HW NT KT BD MM SQ. Wrote the paper: RH CD AR AT HW JM LS
JD SM.
References
1. Mackay J, Mensah G (2004) The atlas of heart disease and stroke. Geneva:
World Health Organisation. 112 p.
2. Stroke Unit Trialists Collaboration (2002) Organised inpatient (stroke unit) care
for stroke. Cochrane Database Syst Rev 4: CD000197.
3. Xian Y, Holloway RG, Chan PS, Noyes K, Shah MN, et al. (2011) Association
between stroke center hospitalization for acute ischemic stroke and mortality.
JAMA 305: 373–380.
4. Healthcare for London (2007) A Framework For Action. Available: http://www.
nhshistory.net/darzilondon.pdf. Accessed 1 July 2013.
5. Hoffman A, Grant R, Wurie F, Campbell J, Lowe D, et al. (2009) The National
Sentinel Audit of Stroke 2008. London: Royal College of Physicians. 114 p.
6. Healthcare for London (2008) Stroke strategy for London. Available: http://
www.londonhp.nhs.uk/wp-content/uploads/2011/03/London-Stroke-Strategy.
pdf. Accessed 1 July 2013.
7. Healthcare for London (2009) Stroke acute commissioning and tariff guidance.
Healthcare for London. Available: http://www.londonhp.nhs.uk/wp-content/
uploads/2011/03/Stroke-Commissioning-and-Tariff-Guidance.pdf. Accessed 1
July 2013.
8. Sarker SJ, Heuschmann PU, Burger I, Wolfe CD, Rudd AG, et al. (2008)
Predictors of survival after haemorrhagic stroke in a multi-ethnic population: the
South London Stroke Register (SLSR). J Neurol Neurosurg Psychiatry 79: 260–
265.
9. Wolfe CD, Crichton SL, Heuschmann PU, McKevitt CJ, Toschke AM, et al.
(2011) Estimates of outcomes up to ten years after stroke: analysis from the
prospective South London Stroke Register. PLoS Med 8: e1001033. 10.
10. Hensage U, Hoffman A, Kavanagh S, Roughton M, Rudd AG, et al. (2011) The
National Sentinel Audit of Stroke 2010. London: Royal College of Physicians.
78 p.
11. Kaambwa B, Billingham L, Bryan S (2013) Mapping utility scores from the
Barthel index. Eur J Health Econ 14: 231–241.
12. Briggs A, Claxton K, Schulper M (2006) Decision Modelling for Health
Economic Evaluation. Oxford: Oxford University Press. 256 p.
13. NHS Information Centre (2011) Emergency hospital admissions: stroke:
indirectly standardised rate, all ages, annual trend, P. Available: https://
indicators.ic.nhs.uk/download/NCHOD/Data/10C_528ISR7CP_11_V1_D.
xls.Accessed 1 July 2013.
14. National Institute for Health and Clinical Excellence (2008) Guide to the
methods of technology appraisal. London: NICE publications. 76 p.
15. XE.COM INC (2012) XE Currency Converter. Available: http://www.xe.com/
. Accessed 5 October 2012.
16. Sheehan J (2009) Pre-consultation business case - Major trauma and stroke
services in London. London: Healthcare for London. 145 p.
17. Middleton S, McElduff P, Ward J, Grimshaw JM, Dale S, et al. (2011)
Implementation of evidence-based treatment protocols to manage fever,
hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster
randomised controlled trial. Lancet 378: 1699–1706.
18. National Audit Office (2010) Progress in improving stroke care: report on the
findings from our modelling of stroke provision. Available: http://www.nao.org.
uk/wp-content/uploads/2010/02/0910291_modelling.pdf. Accessed 1 July
2013.
19. Saka O, Serra V, Samyshkin Y, McGuire A, Wolfe CC (2009) Cost-effectiveness
of stroke unit care followed by early supported discharge. Stroke 40: 24–29.
20. Youman P, Wilson K, Harraf F, Kalra L (2003) The economic burden of stroke
in the United Kingdom. Pharmacoeconomics 21 Suppl 1: 43–50.
21. Quinn TJ, Langhorne P, Stott DJ (2011) Barthel Index for stroke trials:
development, properties and application. Stroke 42: 1146–1151.
Impact of Centralized Stroke Care in London
PLOS ONE | www.plosone.org 9 August 2013 | Volume 8 | Issue 8 | e70420